the unmet needs of patients who have visual impairment as a consequence of scd
Published 12 hours ago • 17 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:35
unmet needs in sickle cell disease
-
3:24
the impact of biological sex in sickle cell disease
-
1:08
managing chronic pain in patients with sickle cell disease
-
2:58
long-term updates from the reach trial of hydroxyurea in pediatric patients with scd in ssa
-
12:07
how to raise hemoglobin naturally | sickle cell chats | healing blends global
-
3:51
sickle cell disease | moa animation
-
14:10
patient perspective: the journey of pain in sickle cell disease
-
1:36
determinants of severity in sickle cell disease
-
2:48
the promise of pyruvate kinase activators, such as mitapivat, for treating scd and thalassemia
-
1:23
the cardiac rhythm in thalassemia: increased incidence of atrial fibrillation and stroke
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
2:05
an insight into the role of the sickle cell society
-
0:59
the safety and efficacy of etavopivat in scd
-
1:36
the limitations and future of precision medicine in sickle cell disease
-
3:02
the recent withdrawal of voxelotor from the market: the potential impact on patients with scd
-
1:27
insights into the phase iii cervino trial: abbv-383 for r/r myeloma
-
1:31
bone disease in patients with thalassemia
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
2:22
how hematologists can improve care for patients with sickle cell disease
-
2:23
improved clinician-reported outcomes with voxelotor in patients with scd: phase iii hope trial
-
1:11
precision medicine in sickle cell disease: current status and future outlooks